Adele Clarkson

5.8k total citations
69 papers, 3.6k citations indexed

About

Adele Clarkson is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Adele Clarkson has authored 69 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 22 papers in Pulmonary and Respiratory Medicine and 20 papers in Molecular Biology. Recurrent topics in Adele Clarkson's work include Pituitary Gland Disorders and Treatments (11 papers), Genetic factors in colorectal cancer (11 papers) and Medical Imaging and Pathology Studies (9 papers). Adele Clarkson is often cited by papers focused on Pituitary Gland Disorders and Treatments (11 papers), Genetic factors in colorectal cancer (11 papers) and Medical Imaging and Pathology Studies (9 papers). Adele Clarkson collaborates with scholars based in Australia, New Zealand and United States. Adele Clarkson's co-authors include Anthony J. Gill, Roderick Clifton‐Bligh, Bruce G. Robinson, Loretta Sioson, Angela Chou, Christopher W. Toon, Deborah J. Marsh, Diana E. Benn, Nicole Watson and Amy Sheen and has published in prestigious journals such as PLoS ONE, Endocrine Reviews and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Adele Clarkson

68 papers receiving 3.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adele Clarkson Australia 38 1.3k 1.0k 947 808 794 69 3.6k
Rob B. van der Luijt Netherlands 28 931 0.7× 242 0.2× 802 0.8× 445 0.6× 782 1.0× 64 2.7k
Snjezana Doğan United States 31 2.0k 1.5× 1.4k 1.3× 1.2k 1.2× 1.3k 1.6× 565 0.7× 89 4.6k
Martin Bäckdahl Sweden 34 612 0.5× 297 0.3× 845 0.9× 1.4k 1.7× 1.3k 1.6× 73 3.1k
Valeria Barresi Italy 30 1.1k 0.8× 746 0.7× 698 0.7× 733 0.9× 457 0.6× 224 3.3k
Frederik J. Hes Netherlands 38 1.3k 1.0× 451 0.4× 1.2k 1.2× 1.2k 1.4× 1.7k 2.2× 136 4.1k
Clara S. Heffess United States 34 2.5k 1.8× 660 0.6× 544 0.6× 2.5k 3.1× 544 0.7× 47 4.6k
Randall D. Gaz United States 25 1.0k 0.8× 375 0.4× 524 0.6× 593 0.7× 112 0.1× 43 2.6k
Robert C. Hickey United States 33 1.0k 0.8× 470 0.4× 358 0.4× 1.6k 1.9× 526 0.7× 85 3.6k
Angela Chou Australia 29 885 0.7× 609 0.6× 541 0.6× 675 0.8× 567 0.7× 77 2.2k
Loretta Sioson Australia 25 719 0.5× 688 0.7× 314 0.3× 352 0.4× 280 0.4× 55 1.7k

Countries citing papers authored by Adele Clarkson

Since Specialization
Citations

This map shows the geographic impact of Adele Clarkson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adele Clarkson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adele Clarkson more than expected).

Fields of papers citing papers by Adele Clarkson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adele Clarkson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adele Clarkson. The network helps show where Adele Clarkson may publish in the future.

Co-authorship network of co-authors of Adele Clarkson

This figure shows the co-authorship network connecting the top 25 collaborators of Adele Clarkson. A scholar is included among the top collaborators of Adele Clarkson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adele Clarkson. Adele Clarkson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fuchs, Talia L., Catherine Luxford, Adele Clarkson, et al.. (2022). A Clinicopathologic and Molecular Analysis of Fumarate Hydratase–deficient Pheochromocytoma and Paraganglioma. The American Journal of Surgical Pathology. 47(1). 25–36. 11 indexed citations
2.
Chou, Angela, Malinda Itchins, Philip R. de Reuver, et al.. (2018). ATRX loss is an independent predictor of poor survival in pancreatic neuroendocrine tumors. Human Pathology. 82. 249–257. 38 indexed citations
3.
Andrici, Juliana, Mahtab Farzin, Loretta Sioson, et al.. (2016). Mismatch repair deficiency as a prognostic factor in mucinous colorectal cancer. Modern Pathology. 29(3). 266–274. 40 indexed citations
4.
Wang, Jennifer, Juliana Andrici, Loretta Sioson, et al.. (2016). Loss of INI1 expression in colorectal carcinoma is associated with high tumor grade, poor survival, BRAFV600E mutation, and mismatch repair deficiency. Human Pathology. 55. 83–90. 19 indexed citations
5.
Chou, Angela, Sheila Fraser, Christopher W. Toon, et al.. (2014). A Detailed Clinicopathologic Study of ALK-translocated Papillary Thyroid Carcinoma. The American Journal of Surgical Pathology. 39(5). 652–659. 77 indexed citations
6.
Elston, Marianne S., Goswin Y. Meyer‐Rochow, Helen M. Conaglen, et al.. (2014). Increased SSTR2A and SSTR3 expression in succinate dehydrogenase–deficient pheochromocytomas and paragangliomas. Human Pathology. 46(3). 390–396. 52 indexed citations
7.
Toon, Christopher W., Adele Clarkson, Loretta Sioson, et al.. (2014). Reflex ALK immunohistochemistry is feasible and highly specific for ALK gene rearrangements in lung cancer. Pathology. 46(5). 383–388. 29 indexed citations
8.
Chou, Angela, Christopher W. Toon, Adele Clarkson, et al.. (2014). Loss of ARID1A expression in colorectal carcinoma is strongly associated with mismatch repair deficiency. Human Pathology. 45(8). 1697–1703. 63 indexed citations
9.
Toon, Christopher W., Angela Chou, Joseph Chan, et al.. (2013). BRAFV600E immunohistochemistry in conjunction with mismatch repair status predicts survival in patients with colorectal cancer. Modern Pathology. 27(5). 644–650. 50 indexed citations
10.
Farzin, Mahtab, Christopher W. Toon, Adele Clarkson, Loretta Sioson, & Anthony J. Gill. (2013). BRAF V600E mutation specific immunohistochemistry with clone VE1 is not reliable in pituitary adenomas. Pathology. 46(1). 79–80. 5 indexed citations
11.
Bullock, Martyn, Christine J. O’Neill, Angela Chou, et al.. (2012). Utilization of a MAB for BRAFV600E detection in papillary thyroid carcinoma. Endocrine Related Cancer. 19(6). 779–784. 61 indexed citations
12.
Chou, Angela, Jason Chen, Adele Clarkson, et al.. (2012). Succinate dehydrogenase-deficient GISTs are characterized by IGF1R overexpression. Modern Pathology. 25(9). 1307–1313. 42 indexed citations
13.
Gill, Anthony J., Nicholas Pachter, Angela Chou, et al.. (2011). Renal Tumors Associated With Germline SDHB Mutation Show Distinctive Morphology. The American Journal of Surgical Pathology. 35(10). 1578–1585. 138 indexed citations
14.
Hahn, Michael, Kristie-Ann Dickson, Stuart D. Jackson, et al.. (2011). The tumor suppressor CDC73 interacts with the ring finger proteins RNF20 and RNF40 and is required for the maintenance of histone 2B monoubiquitination. Human Molecular Genetics. 21(3). 559–568. 70 indexed citations
15.
Gill, Anthony J., Angela Chou, Ricardo E. Vilain, et al.. (2010). Immunohistochemistry for SDHB Divides Gastrointestinal Stromal Tumors (GISTs) into 2 Distinct Types. The American Journal of Surgical Pathology. 34(5). 636–644. 150 indexed citations
16.
Soon, Patsy, Anthony J. Gill, Adele Clarkson, et al.. (2009). Microarray gene expression and immunohistochemistry analyses of adrenocortical tumors identify IGF2 and Ki-67 as useful in differentiating carcinomas from adenomas. Endocrine Related Cancer. 16(2). 573–583. 105 indexed citations
17.
Howell, Viive M., Anthony J. Gill, Adele Clarkson, et al.. (2008). Accuracy of Combined Protein Gene Product 9.5 and Parafibromin Markers for Immunohistochemical Diagnosis of Parathyroid Carcinoma. The Journal of Clinical Endocrinology & Metabolism. 94(2). 434–441. 97 indexed citations
18.
Gill, Anthony J., Adele Clarkson, Oliver Gimm, et al.. (2006). Loss of Nuclear Expression of Parafibromin Distinguishes Parathyroid Carcinomas and Hyperparathyroidism-Jaw Tumor (HPT-JT) Syndrome-related Adenomas From Sporadic Parathyroid Adenomas and Hyperplasias. The American Journal of Surgical Pathology. 30(9). 1140–1149. 159 indexed citations
19.
Scarlett, Christopher J., et al.. (2005). Assessment of HER-2 Status in Pancreatic Adenocarcinoma. The American Journal of Surgical Pathology. 29(9). 1125–1134. 45 indexed citations
20.
Cheung, Linda, Marinella Messina, Anthony J. Gill, et al.. (2003). Detection of the PAX8-PPARγ Fusion Oncogene in Both Follicular Thyroid Carcinomas and Adenomas. The Journal of Clinical Endocrinology & Metabolism. 88(1). 354–357. 152 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026